The stem-cell profile of ovarian surface epithelium is reproduced in the oviductal fimbriae, with increased stem-cell marker density in distal parts of the fimbriae

International Journal of Gynecological Pathology

Volumn 32, Issue 5, 2013, Pages 444-453

  Auersperg, Nelly ^a  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

Author keywords

Fallopian tube; Immunohistochemistry; Ovarian cancer; Ovarian carcinogenesis; Ovarian surface epithelium; Stem cells

Indexed keywords

ALDEHYDE DEHYDROGENASE; CELL MARKER; FORMALDEHYDE; PROTEIN ALDH1A1; PROTEIN ALDH1A2; PROTEIN LHX9; SECRETED FRIZZLED RELATED PROTEIN 1; TRANSCRIPTION FACTOR NANOG; UNCLASSIFIED DRUG; ALDH1A1 PROTEIN, HUMAN; ALDH1A2 PROTEIN, HUMAN; BIOLOGICAL MARKER; HOMEODOMAIN PROTEIN; LHX9 PROTEIN, HUMAN; LIM HOMEODOMAIN PROTEIN; MEMBRANE PROTEIN; NANOG PROTEIN, HUMAN; RETINAL DEHYDROGENASE; SFRP1 PROTEIN, HUMAN; SIGNAL PEPTIDE; TRANSCRIPTION FACTOR;

ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DENSITY; EPITHELIUM OF OVIDUCTAL FIMBRIAE; FEMALE; FIMBRIA; HUMAN; IMMUNOHISTOCHEMISTRY; OVARIAN SURFACE EPITHELIUM; OVARY CANCER; OVARY FUNCTION; OVIDUCT; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; SECRETORY CELL; STEM CELL; ADOLESCENT; ADULT; CARCINOMA; CELL TRANSFORMATION; EPITHELIUM; EPITHELIUM CELL; METABOLISM; NEOPLASM; OVARY; OVARY TUMOR; PATHOLOGY; UTERINE TUBE; YOUNG ADULT;

ADOLESCENT; ADULT; ALDEHYDE DEHYDROGENASE; BIOLOGICAL MARKERS; CARCINOMA; CELL TRANSFORMATION, NEOPLASTIC; EPITHELIAL CELLS; EPITHELIUM; FALLOPIAN TUBES; FEMALE; HOMEODOMAIN PROTEINS; HUMANS; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; LIM-HOMEODOMAIN PROTEINS; MEMBRANE PROTEINS; NEOPLASMS, GLANDULAR AND EPITHELIAL; OVARIAN NEOPLASMS; OVARY; RETINAL DEHYDROGENASE; STEM CELLS; TRANSCRIPTION FACTORS; YOUNG ADULT;

EID: 84883455775     PISSN: 02771691     EISSN: 15387151     Source Type: Journal    
DOI: 10.1097/PGP.0b013e3182800ad5     Document Type: Article

References (26)

1. Pothuri B, Leietao MM, Levine DA, et al. Genetic analysis of the early natural history of epithelial ovarian carcinoma. PLoS One 2010;5:e10358.
2. Kurman RJ, Shih IeM. Molecular pathogenesis and extraovarian origin of epithelial ovarian cancer-shifting the paradigm. Hum Pathol 2011;42:918-31. Review
3. Auersperg N. The origin of ovarian carcinomas: a unifying hypothesis. Int J Gynecol Pathol 2011;30:12-21.
4. Conic I, Dimov I, Tasic-Dimov D, et al. Ovarian epithelial cancer stem cells. ScientificWorldJournal 2011;11:1243-69.
5. Bowen NJ, Walker LD, Matyunina LV, et al. Gene expression profiling supports the hypothesis that human ovarian surface epithelia are multipotent and capable of serving as ovarian cancer initiating cells. BMC Med Genomics 2009;2:71.
6. Mullin NP, Yates A, Rowe AJ, et al. The pluripotency rheostat Nanog functions as a dimer. Biochem J 2008;411: 227-31.
7. Ambady S, Malcuit C, Kashpur O, et al. Expression of NANOG and NANOGP8 in a variety of undifferentiated and differentiated human cells. Int J Dev Biol 2010;54: 1743-54.
8. Dahl L, Richter K, Hagglund AC, et al. Lhx2 expression promotes self-renewal of a distinct multipotential hematopoietic progenitor cell in embryonic stem cell-derived embryoid bodies. PLoS One 2008;3:e2025.
9. Rhee H, Polak L, Fuchs E. Lhx2 maintains stem cell character in hair follicles. Science 2006;312:1946-9.
10. De Sousa E, Melo F, Medema JP. Axing Wnt signals. Cell Res 2012;22:9-11.
11. Hanahan D, Weinberg RA. The hallmarks of cancer. Cell 2000;100:57-70.
12. Gatcliffe TA, Monk BJ, Planutis K, et al. Wnt signaling in ovarian tumorigenesis. Int J Gynecol Cancer 2008;18: 954-62.
13. Barbolina MV, Burkhalter RJ, Stack MS. Diverse mechanisms for activation of Wnt signalling in the ovarian tumour microenvironment. Biochem J 2011;437:1-12(Review).
14. Landen CN, Jr Goodman B, Katre AA, et al. Targeting aldehyde dehydrogenase cancer stem cells in ovarian cancer. Mol Cancer Ther 2010;9:3186-99.
15. Steg AD, Bevis KS, Katre AA, et al. Stem cell pathways contribute to clinical chemoresistance in ovarian cancer. Clin Cancer Res 2012;18:869-81.
16. Crum CP, McKeon FD, Xian W. The oviduct and ovarian cancer: causality, clinical implications, and targeted prevention. Clin Obstet Gynecol 2012;55:24-35.
17. Kuhn E, Kurman RJ, Sehdev AS, et al. Ki-67 labeling index as an adjunct in the diagnosis of serous tubal intraepithelial carcinoma. Int J Gynecol Pathol 2012;31:416-22.
18. Auersperg N, Wong AS, Choi KC, et al. Ovarian surface epithelium: biology, endocrinology, and pathology. Endocr Rev 2001;22:255-88(Review).
19. Strauss R, Li ZY, Liu Y, et al. Analysis of epithelial and mesenchymal markers in ovarian cancer reveals phenotypic heterogeneity and plasticity. PLoS One 2011;6:e16186.
20. Erratum in: PLoS One. 2011;6(2).
21. Hu L, McArthur C, Jaffe RB. Ovarian cancer stem-like sidepopulation cells are tumourigenic and chemoresistant. Br J Cancer 2010;102:1276-83.
22. Abellan A, Menuet A, Dehay C, et al. Differential expression of LIM-homeodomain factors in Cajal-Retzius cells of primates, rodents, and birds. Cereb Cortex 2010;20: 1788-98.
23. Kinzler KW, Vogelstein B. Lessons from hereditary colorectal cancer. Cell 1996;87:159-70. Review
24. Li Y, Laterra J. Cancer stem cells: distinct entities or dynamically regulated phenotypes? Cancer Res 2012;72:576-80. Review
25. Li l, Neaves WB. Normal stem cells and cancer stem cells: the niche matters. Cancer Res 2006;66:4553-7.
26. Auersperg N. The origin of ovarian cancers-hypotheses and controversies. Front Biosci 2013;S5:709-19.